Soumili Chattopadhyay

Soumili Chattopadhyay is a Scientist 1 at Rondo Therapeutics since March 2023, with previous experience as an Associate Scientist at Vaxart, Inc. and Vaxcyte. Soumili has expertise in analytical method development for vaccines and biologics, including working on adenovirus vector platforms, protein-polysaccharide conjugate vaccines, and biosimilar mAb projects. Soumili holds a Master of Chemical Engineering from the Indian Institute of Technology, Delhi, and the University of Delaware.